Image-Guided Radiotherapy and Chemotherapy in Gynaecological Cancer

CEOS

p

Figure 3: Cancer specific overall survival.

Stage

Ib2-IIB

83%

0,001

III-Iva

41%

Histology

squamous

78%

ns

adenocarcinoma

59,7%

Lymph node involvement

N0

85

0,01

Cancer specific overall survival at 5 years: 74%

Npelvic-paraortic+ 72 Npelvic+paraortic+ 35

ERT

3D

66.5% ns

IMRT

75,3%

CTV-HR dose <85 Gy

77%

ns

>85 Gy

82,5&

CTV-HR volumen

< 30 cc

81,8% ns

>30 cc

67%